Skip to the reading

Guidebook · Evidence notes

Healing claims need human proof.

A useful reading check is simple: who was studied, what was compared, and what changed?

The misconception

Misconception: healing results in animals prove the same benefit in people.

What holds up

Animal results leave a human question open.

Most BPC-157 research concerns animals, including rats with injured tendons.

A dummy treatment looks like treatment but contains no BPC-157. As of September 2026, no completed injury study comparing BPC-157 with a dummy treatment had reported results.

Evidence · A

Read a claim with these checks

  • Look for people, rather than animal findings alone.

    The published results about tendon healing come from rats. Tendons join muscles to bones; these animal results do not show that BPC-157 heals injuries in people.

  • Find out what the researchers compared.

    A comparison group is another group of people in the study. They get a different treatment, a dummy treatment, or no treatment. Comparing the groups helps researchers judge what caused a change.

  • Ask how improvement was measured.

    The knee-pain report relied on what patients said. It had no comparison group or set way to measure movement and daily activities. Most patients said they felt better, but this does not show that BPC-157 caused the change.

A change after treatment is worth noticing. It still leaves the question of what caused it.

Evidence · B

The human evidence in perspective

The FDA’s July 2026 review found 5 human studies.
With a comparison
2 studies: one in healthy volunteers and one in people with a bowel disease. Only short summaries were published, so readers lack the detail of a full study paper.
Without a comparison
3 small reports: knee pain, a painful bladder condition, and BPC-157 given through a vein to healthy adults.

The healthy-volunteer study reported headache and gas about as often with BPC-157 as with the dummy treatment.

The bowel-disease study used an enema, meaning liquid treatment put into the rectum, the last part of the bowel. FDA said the results were not enough to show that BPC-157 helped that disease.

That trial cannot fill the gap in evidence for an injury. Ask about findings that match the problem under discussion.

Evidence · A

Page evidence

  1. FDA review: human experience and its limits

    The review brings together studies in people, including the two studies with comparison groups and the three small reports.

  2. PubMed: the knee-pain report

    The linked page has a short summary of the knee-pain report. Most patients said their pain improved, but there was no comparison group to show why.